Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06307795
Status:
RECRUITING
Last Update Posted:
2024-03-13
First Post:
2024-03-05
Brief Title:
A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors
Sponsor:
Avistone Biotechnology Co Ltd
Organization:
Avistone Biotechnology Co Ltd
Study Overview
Official Title:
A Phase 1 Study Evaluating the Safety Tolerability Pharmacokinetics and Preliminary Efficacy of ANS014004 as a Single Agent in Participants With Locally Advanced or Metastatic Solid Tumors
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a Phase 1 first-in-human open-label multi-center study with the aim of exploring the safety tolerability PK and preliminary anti-tumor activity of ANS014004 as a single agent in participants with locally advanced or metastatic solid tumors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None